PCSAProcessa Pharmaceuticals, Inc.

Nasdaq processapharmaceuticals.com


$ 2.14 $ -0.04 (-1.88 %)    

Thursday, 09-May-2024 15:18:33 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 2.09
$ 2.38
$ 2.11 x 200
$ 0.00 x 0
$ 2.14 - $ 2.38
$ 1.40 - $ 18.00
56,712
na
5.16M
$ 1.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-29-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-30-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-25-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-06-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-14-2019 03-31-2019 10-Q
22 03-28-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 05-21-2018 03-31-2018 10-Q
26 04-16-2018 12-31-2017 10-K
27 11-20-2017 09-30-2017 10-Q
28 10-04-2017 06-30-2017 10-Q
29 10-04-2017 03-31-2017 10-Q
30 09-25-2017 12-31-2016 10-K
31 09-08-2017 09-30-2016 10-Q
32 08-30-2017 06-30-2016 10-Q
33 08-07-2017 03-31-2016 10-Q
34 06-19-2017 12-31-2015 10-K
35 12-01-2015 09-30-2015 10-Q
36 08-19-2015 06-30-2015 10-Q
37 05-15-2015 03-31-2015 10-Q
38 04-14-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-19-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-initiates-coverage-on-processa-pharma-with-buy-rating-announces-price-target-of-8

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Processa Pharma (NASDAQ:PCSA) with a Buy rating and...

 benchmark-reiterates-speculative-buy-on-processa-pharma-maintains-4-price-target

Benchmark analyst Robert Wasserman reiterates Processa Pharma (NASDAQ:PCSA) with a Speculative Buy and maintains $4 price ta...

 processa-pharmaceuticals-and-2-other-penny-stocks-insiders-are-buying

The Dow Jones index closed higher by around 150 points on Wednesday. When insiders purchase or sell shares, it indicates their ...

 expensify-and-3-other-stocks-under-3-insiders-are-buying

The Dow Jones index closed higher by more than 350 points on Thursday. When insiders purchase or sell shares, it indicates thei...

 relmada-therapeutics-and-2-other-penny-stocks-insiders-are-buying

The Dow Jones index closed lower by more than 300 points on Wednesday. When insiders purchase or sell shares, it indicates thei...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION